The Livestock Vaccine Innovation Fund (LVIF) is pleased to announce CA$6.3 million in research funding for four new projects.
Livestock vaccine research for development has predominantly focused on the technical aspects of vaccine development, distribution, and adoption. There have been many successes in these areas, but few women have enjoyed the benefits of this research. Social, cultural, and economic factors have contributed to gender inequalities that limit women’s agricultural and livestock productivity.
The new LVIF-funded research projects focus on empowering women so that they can fully benefit from livestock vaccines as users, as entrepreneurs, and as service providers. The research will target women’s participation in the livestock vaccine distribution and delivery chain with a focus on how women can increase their livestock productivity while improving household food security.
LVIF is supported with funding from the Bill & Melinda Gates Foundation, Global Affairs Canada, and IDRC. It represents a joint investment of CA$57 million over seven years (2015-2022) to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia. To date, 19 projects on vaccine development, manufacturing, and delivery have been funded, for a combined total of CA$24.9 million.
Learn more about LVIF's four new research projects:
- Action research to support women’s agency and empowerment in livestock vaccine distribution, delivery and use in Rwanda, Uganda, and Kenya
- Advancing women's participation in livestock vaccine value chains in Nepal, Senegal, and Uganda
- Gender inclusive vaccine ecosystem: enhancing distribution and delivery systems among smallholder farmers in Kenya
- Transforming the vaccine delivery system for chickens and goats in Ghana: what approaches and what benefits for women?